13147-25-6 | N-Ethyl-n-(2-hydroxyethyl)nitrosamine

Packsize	Purity	Availability	Price	Discounted Price
1g	97%	in stock	$31.00	$22.00
5g	97%	in stock	$87.00	$61.00

Description

• Catalog Number: AA41616
• Chemical Name: N-Ethyl-n-(2-hydroxyethyl)nitrosamine
• CAS Number: 13147-25-6
• Molecular Formula: C4H10N2O2
• Molecular Weight: 118.1344
• MDL Number: MFCD01727871
• SMILES: OCCN(N=O)CC

Computed Properties

• Complexity: 67.1
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 8
• Hydrogen Bond Acceptor Count: 4
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 3
• XLogP3: -0.1

Literature

• Phenobarbital mediates an epigenetic switch at the constitutive androstane receptor (CAR) target gene Cyp2b10 in the liver of B6C3F1 mice.

  PloS one 20110101

• Chelation in metal intoxication.

  International journal of environmental research and public health 20100701

• Potassium bromate enhances N-ethyl-N-hydroxyethylnitrosamine-induced kidney carcinogenesis only at high doses in Wistar rats: indication of the existence of an enhancement threshold.

  Toxicologic pathology 20091201

• Etiology of bromate-induced cancer and possible modes of action-studies in Japan.

  Toxicology 20060417

• Distinction of carcinogens from mutagens by induction of liver cell foci in a model for detection of initiation activity.

  Cancer letters 20021215

• N-ethyl-N-hydroxyethylnitrosamine (EHEN)-induced renal and hepatocarcinogenesis in the tumor suppressor Tsc2 transgenic rat.

  Cancer letters 20021028

• Down-regulation of von Hippel-Lindau protein in N-nitroso compound-induced rat non-clear cell renal tumors.

  Cancer letters 20020508

• Microsome-mediated oxidation of N-nitrosodiethanolamine (NDELA), a bident carcinogen.

  Chemical research in toxicology 20020401

• Strain variation in renal carcinogenesis by N-ethyl-N-hydroxyethylnitrosamine in F1 (Wistar-Fischer) rats.

  Cancer letters 20010920

• Establishment and characterization of three new rat renal cell carcinoma cell lines from N-ethyl-N-hydroxyethylnitrosamine-induced basophilic cell tumors.

  Pathology international 20010201

• Specific genomic alterations in rat renal cell carcinomas induced by N-ethyl-N-hydroxyethylnitrosamine.

  Toxicologic pathology 20010101

• Effects of n-tritriacontane-16,18-dione, curcumin, chlorphyllin, dihydroguaiaretic acid, tannic acid and phytic acid on the initiation stage in a rat multi-organ carcinogenesis model.

  Cancer letters 19970226

• Decreased connexin32 and a characteristic enzyme phenotype in clofibrate-induced preneoplastic lesions not shared with spontaneously occurring lesions in the rat liver.

  Carcinogenesis 19961101

• Absence of ras family point mutations at codons 12, 13 and 61 in N-ethyl-N-hydroxyethylnitrosamine- or N-nitrosomorpholine-induced renal cell tumors in rats.

  Japanese journal of cancer research : Gann 19920901

• Modifying effects of various chemicals on tumor development in a rat wide-spectrum organ carcinogenesis model.

  Japanese journal of cancer research : Gann 19920801

• Modifying effects of the naturally occurring antioxidants gamma-oryzanol, phytic acid, tannic acid and n-tritriacontane-16, 18-dione in a rat wide-spectrum organ carcinogenesis model.

  Carcinogenesis 19911001

• Synergistic effects of low-dose hepatocarcinogens in induction of glutathione S-transferase P-positive foci in the rat liver.

  Japanese journal of cancer research : Gann 19891001

• Changes in gap junction protein (connexin 32) gene expression during rat liver carcinogenesis.

  Journal of cellular biochemistry 19891001

• Reciprocal modifying effects of isomeric forms of aminophenol on induction of neoplastic lesions in rat liver and kidney initiated by N-ethyl-N-hydroxyethylnitrosamine.

  Carcinogenesis 19870901

• Inhibition of neoplastic development in rat liver, kidney, oesophagus and forestomach by 4,4'-diaminodiphenylmethane administration.

  Carcinogenesis 19870501

• Modifying effects of butylated hydroxyanisole, ethoxyquin and acetaminophen on induction of neoplastic lesions in rat liver and kidney initiated by N-ethyl-N-hydroxyethylnitrosamine.

  Carcinogenesis 19840401

• Modification of chemical carcinogenesis by antioxidants.

  Princess Takamatsu symposia 19830101

• Inhibitory effect of 4,4'-diaminodiphenylmethane on liver, kidney and bladder carcinogenesis in rats ingesting N-ethyl-N-hydroxyethylnitrosamine or N-butyl-N-(4-hydroxybutyl) nitros-amine.

  Carcinogenesis 19810101